These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30497262)

  • 41. Local lazy regression: making use of the neighborhood to improve QSAR predictions.
    Guha R; Dutta D; Jurs PC; Chen T
    J Chem Inf Model; 2006; 46(4):1836-47. PubMed ID: 16859315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico ADME/T modelling for rational drug design.
    Wang Y; Xing J; Xu Y; Zhou N; Peng J; Xiong Z; Liu X; Luo X; Luo C; Chen K; Zheng M; Jiang H
    Q Rev Biophys; 2015 Nov; 48(4):488-515. PubMed ID: 26328949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.
    Su BH; Shen MY; Esposito EX; Hopfinger AJ; Tseng YJ
    J Chem Inf Model; 2010 Jul; 50(7):1304-18. PubMed ID: 20565102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in high throughput screening for ADME properties.
    Carlson TJ; Fisher MB
    Comb Chem High Throughput Screen; 2008 Mar; 11(3):258-64. PubMed ID: 18336218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take?
    Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A
    J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of Novel HIV-1 Integrase Inhibitors Using QSAR-Based Virtual Screening of the NCI Open Database.
    Ko GM; Garg R; Bailey BA; Kumar S
    Curr Comput Aided Drug Des; 2016; 12(2):135-53. PubMed ID: 27076270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring Tunable Hyperparameters for Deep Neural Networks with Industrial ADME Data Sets.
    Zhou Y; Cahya S; Combs SA; Nicolaou CA; Wang J; Desai PV; Shen J
    J Chem Inf Model; 2019 Mar; 59(3):1005-1016. PubMed ID: 30586300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An integrated computational workflow for efficient and quantitative modeling of renin inhibitors.
    Subramanian G; Rao SN
    Bioorg Med Chem; 2012 Jan; 20(2):851-8. PubMed ID: 22200345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3D-QSAR in drug design--a review.
    Verma J; Khedkar VM; Coutinho EC
    Curr Top Med Chem; 2010; 10(1):95-115. PubMed ID: 19929826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Bioactive Scaffolds Based on QSAR Models.
    Nakagawa T; Miyao T; Funatsu K
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29135084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
    Martin E; Mukherjee P
    J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. General Approach to Estimate Error Bars for Quantitative Structure-Activity Relationship Predictions of Molecular Activity.
    Liu R; Glover KP; Feasel MG; Wallqvist A
    J Chem Inf Model; 2018 Aug; 58(8):1561-1575. PubMed ID: 29949366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using Cheminformatics in Drug Discovery.
    Lawless MS; Waldman M; Fraczkiewicz R; Clark RD
    Handb Exp Pharmacol; 2016; 232():139-68. PubMed ID: 26318607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening.
    Ballante F; Caroli A; Wickersham RB; Ragno R
    J Chem Inf Model; 2014 Mar; 54(3):956-69. PubMed ID: 24564321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
    Zaka M; Abbasi BH; Durdagi S
    J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multi-objective Optimization of Benzamide Derivatives as Rho Kinase Inhibitors.
    Cardoso Gajo G; Rodrigues Silva D; Barigye SJ; da Cunha EFF
    Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28876533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Silico and in Vitro Assessment of OATP1B1 Inhibition in Drug Discovery.
    Danielson ML; Sawada GA; Raub TJ; Desai PV
    Mol Pharm; 2018 Aug; 15(8):3060-3068. PubMed ID: 29927611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.